(Q34976053)

5 August 2017

Extracorporeal photochemotherapy--the Columbia Presbyterian experience (English)

1 reference

5 August 2017

Elizabeth Knobler

1

1 reference

5 August 2017

Ingrid Warmuth

2

1 reference

5 August 2017

Carolyn Cocco

3

1 reference

5 August 2017

Barbara Miller

4

1 reference

5 August 2017

Julian Mackay

5

1 reference

5 August 2017

1 October 2002

1 reference

Photodermatology, Photoimmunology and Photomedicine

5 August 2017

1 reference

5 August 2017

18

1 reference

5 August 2017

5

1 reference

5 August 2017

232-237

1 reference

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

5 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Photopheresis therapy for cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Effectiveness of photopheresis in Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Proceedings of the International Consensus Conference on Cutaneous T-cell Lymphoma (CTCL) Treatment Recommendations. Boston, Massachusetts, Oct. 1 and 2, 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

The dynamic interplay of malignant and benign T cells in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Epizootiology of Lyme disease-causing borreliae

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Extracorporeal photopheresis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Cutaneous and noncutaneous disorders treated with extracorporeal photopheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

Prognosis and staging of cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

Photopheresis for the treatment of cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

Induction of human tumor-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

Photopheresis for the treatment of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

Adverse effects associated with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0781.2002.02762.X

7 January 2021

10.1034/J.1600-0781.2002.02762.X

Identifiers

DOI

1 reference

5 August 2017

1 reference